ERA-EDTA and EuroPD: Using synergies to promote peritoneal dialysis in Europe

Peritoneal dialysis (PD) is an important form of treatment for patients with end-stage kidney failure requiring renal replacement therapy, yet the percentage of patients treated with PD is still low in Europe, ranging from 4% in Austria, Norway and parts of Spain to 11% in Denmark and Romania [1]. From the medical perspective, the outcomes of haemodialysis and PD are equivalent, and some specific patient groups, e.g. the young, may even gain by starting their renal replacement therapy on PD. PD also has the major advantage of being a home dialysis therapy.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Urology / Nephrology Source Type: news